Theragenics Corporation (TGX) Launches Galt Centeze™ Centesis Drainage Catheter Line of Products  
10/24/2012 9:36:52 AM

BUFORD, Ga.--(BUSINESS WIRE)--Theragenics Corporation® (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced that Galt Medical (a wholly-owned subsidiary of Theragenics) launched its Centeze™ Centesis Drainage Catheter line. The Centeze™ is a needle and catheter system used to drain and aspirate fluid from the body. Centeze™ will add to the drainage product platform Galt initiated with the Outflow™ all-purpose drainage products launched in 2011. The addressable market in the United States for centesis drainage is estimated to be approximately $9 million annually.